Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome

Cilt: 43 Sayı: 2 1 Haziran 2016
  • Fesih Aktar
  • Kamuran Karaman
  • Berfin Özgökçe Özmen
  • Muhammed Akıl
  • Gökmen Taşkın
  • Hüseyin Çaksen
PDF İndir
TR EN

Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome

Öz

Sjögren-Larsson syndrome (SLS) is a rare neurocutaneous disease showing an autosomal recessive transmission due to a lack of fatty acid aldehyde dehydrogenase. Spastic diplegia or triplegia, mental retardation and congenital lamellar ichthyosis are the major findings of the disease. The syndrome may be accompanied by various eye and teeth features, skeletal system anomaly, speaking defects, hypertelorism and epilepsy. A 9-month male patient has been hospitalized for convulsion and flaking on body. The patient history showed that flaking skin thickening and peeling was started at the birth, and he suffered a right-side focused seizure when he was three month-old and he was treated with phenobarbital and carbamazepine upon the epilepsy diagnosis. Wide ichthyosis, hypertelorism and bilateral simian line were observed in the physical examination. Bilateral punctuate lesions in cornea, pigment epithelial atrophy in the right eye and esotropia in the left eye have been determined during the eye examination. An epiteliform anomaly has been observed in the left hemisphere by electroencephalography. In brain magnetic resonance imaging (MRI), an increase in cerebral-cerebellar brain parenchyma and T1-T2 relaxation time and in the signal in corpus callosum (delayed myelination) have been determined. With the observation of the white matter in centrum semi oval using brain MRI spectroscopy, signs of a sphingolipid peak at 1.3 ppm have been observed. An SLS diagnosis has been proposed upon clinical and laboratory observations. We want to emphasize on the fact that in epilepsy cases with ichthyosis, SLS should be considered.

Anahtar Kelimeler

Kaynakça

  1. 1. Sillén A, Alderborn A, Pigg M, et al. Detailed genetic and physical mapping in the Sjögren Larsson syndrome gene region in 17p11.2. Hereditas 1998;128:245-250.
  2. 2. Fuijkschot J, Theelen T, Seyger MM, et al. Sjögren-Larsson syndrome in clinical practice. J Inherit Metab Dis 2012;35:955-962.
  3. 3. Zribi H, A Souissi, Azzouz H, et al. Sjogren Larsson syndrome: a rare neurocutaneous disease. Rev Neurol (Paris) 2014;170:297-298.
  4. 4. Tanteles GA, Nicolaou M, Patsia N, et al. A rare cause of pruritic ichthyosis: Sjögren-Larsson syndrome in the first reported patients of Cypriot descent. Eur J Dermatol 2015;25:495-496.
  5. 5. Gomori JM, Leibovici V, Ziotogorski A, et al. Computed tomography in Sjögren-Larsson syndrome. Neuroradiology 1987;29:557-559.
  6. 6. Nakayama M, Tavora DG, Alvim TC, et al. MRI and 1HMRS findings of three patients with Sjogren-Larsson syndrome. Arq Neuropsiquiatr 2006;64:398-401.
  7. 7. Willemsen MA, Rotteveel JJ, Steijlen PM, et al. 5-Lipoxygenase inhibition: a new treatment strategy for SjogrenLarsson syndrome. Neuropediatrics 2000;31:1-3.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Fesih Aktar Bu kişi benim

Kamuran Karaman Bu kişi benim

Berfin Özgökçe Özmen Bu kişi benim

Muhammed Akıl Bu kişi benim

Gökmen Taşkın Bu kişi benim

Hüseyin Çaksen Bu kişi benim

Yayımlanma Tarihi

1 Haziran 2016

Gönderilme Tarihi

1 Haziran 2016

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2016 Cilt: 43 Sayı: 2

Kaynak Göster

APA
Aktar, F., Karaman, K., Özgökçe Özmen, B., Akıl, M., Taşkın, G., & Çaksen, H. (2016). Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. Dicle Medical Journal, 43(2), 356-359. https://izlik.org/JA89CX28RH
AMA
1.Aktar F, Karaman K, Özgökçe Özmen B, Akıl M, Taşkın G, Çaksen H. Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. diclemedj. 2016;43(2):356-359. https://izlik.org/JA89CX28RH
Chicago
Aktar, Fesih, Kamuran Karaman, Berfin Özgökçe Özmen, Muhammed Akıl, Gökmen Taşkın, ve Hüseyin Çaksen. 2016. “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”. Dicle Medical Journal 43 (2): 356-59. https://izlik.org/JA89CX28RH.
EndNote
Aktar F, Karaman K, Özgökçe Özmen B, Akıl M, Taşkın G, Çaksen H (01 Haziran 2016) Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. Dicle Medical Journal 43 2 356–359.
IEEE
[1]F. Aktar, K. Karaman, B. Özgökçe Özmen, M. Akıl, G. Taşkın, ve H. Çaksen, “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”, diclemedj, c. 43, sy 2, ss. 356–359, Haz. 2016, [çevrimiçi]. Erişim adresi: https://izlik.org/JA89CX28RH
ISNAD
Aktar, Fesih - Karaman, Kamuran - Özgökçe Özmen, Berfin - Akıl, Muhammed - Taşkın, Gökmen - Çaksen, Hüseyin. “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”. Dicle Medical Journal 43/2 (01 Haziran 2016): 356-359. https://izlik.org/JA89CX28RH.
JAMA
1.Aktar F, Karaman K, Özgökçe Özmen B, Akıl M, Taşkın G, Çaksen H. Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. diclemedj. 2016;43:356–359.
MLA
Aktar, Fesih, vd. “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”. Dicle Medical Journal, c. 43, sy 2, Haziran 2016, ss. 356-9, https://izlik.org/JA89CX28RH.
Vancouver
1.Fesih Aktar, Kamuran Karaman, Berfin Özgökçe Özmen, Muhammed Akıl, Gökmen Taşkın, Hüseyin Çaksen. Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. diclemedj [Internet]. 01 Haziran 2016;43(2):356-9. Erişim adresi: https://izlik.org/JA89CX28RH